1. Specific Gut Microbial Environment in Lard Diet-Induced Prostate Cancer Development and Progression.
- Author
-
Sato H, Narita S, Ishida M, Takahashi Y, Mingguo H, Kashima S, Yamamoto R, Koizumi A, Nara T, Numakura K, Saito M, Yoshioka T, and Habuchi T
- Subjects
- Animals, Clostridiales physiology, Dietary Fats, Unsaturated metabolism, Fatty Acids metabolism, Feces microbiology, Lipid Metabolism physiology, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Obesity metabolism, Obesity microbiology, Obesity physiopathology, Prostatic Neoplasms metabolism, Weight Gain physiology, Diet, High-Fat adverse effects, Gastrointestinal Microbiome physiology, Prostatic Neoplasms microbiology, Prostatic Neoplasms physiopathology
- Abstract
Lard diet (LD) is a risk factor for prostate cancer (PCa) development and progression. Two immunocompetent mouse models fed with isocaloric specific fat diets (LD) enriched in saturated and monounsaturated fatty acid (SMFA), showed significanftly enhanced PCa progression with weight gain compared with a fish oil diet (FOD). High gut microbial divergency resulted from difference in diets, and the abundance of several bacterial species, such as in the orders Clostridiales and Lactobacillales, was markedly altered in the feces of LD- or FOD-fed mice. The proportion of the order Lactobacillales in the gut was negatively involved in SMFA-induced body weight gain and PCa progression. We found the modulation of lipid metabolism and cholesterol biosynthesis pathways with three and seven commonly up- and downregulated genes in PCa tissues, and some of them correlated with the abundance of the order Lactobacillales in mouse gut. The expression of sphingosine 1-phosphate receptor 2, which is associated with the order Lactobacillales and cancer progression in mouse models, was inversely associated with aggressive phenotype and weight gain in patients with PCa using the NCBI Gene Expression Omnibus database. Therefore, SMFA may promote PCa progression with the abundance of specific gut microbial species and overexpression of lipogenic genes in PCa. Therapeutics with alteration of gut microbiota and candidate genes involved in diet-induced PCa progression may be attractive in PCa.
- Published
- 2022
- Full Text
- View/download PDF